Connell Consulting
HealthInvestor Awards Winners 2014
 
 
Remember me:
Skip Navigation Links
Philip Scott checks out of Priory

Philip Scott (pictured) is to quit his role as chief executive of The Priory Group. 
 
In a statement issued on 4 July, the mental health giant said that, after five years at the helm, Scott felt "unable to commit for a further five years".
 
It characterised the decision as "completely amicable”, and said that Scott was now working with chairman Mike Jeffries to find a successor.
 
"I have greatly enjoyed my time at the Priory,” Scott said in a statement. “Having overseen the sale of the Group to Advent International in January 2011 and the subsequent purchase and integration of Craegmoor in April 2011, I feel that now is the right time to pursue opportunities elsewhere. 
 
"Until my successor has been appointed, though, it is very much business as usual and I remain committed to building on our strong financial performance to date.”
 
Advent acquired the Priory Group in January last year, in a £925 million deal. But in November, the group reduced its earnings forecast by 7%, blaming the squeeze on NHS budgets for a fall in patients. 
 
Revenues for the year to 31 December 2011 dropped slightly, to £455.4 million (2010: £456.1 million). And Scott warned that earnings this year would be disrupted by commissioning reforms in the NHS.
 
Scott joined the Priory Group in 2007, after seven years at Southern Cross.
 
It is not clear whether he will retain his equity stake in the business, or continue to rent various care properties back to the Priory Group.

Posted on: 05/07/2012

Latest news stories

30/09/2014
David Cameron has pledged that everyone in England will have access to GPs seven days a week by 2020.
30/09/2014
Three NHS trusts have ended their human resources contracts with outsourcing firm Capita this month.
29/09/2014
Montreux Capital Management and Macquarie Lending have announced the acquisition of The Regard Partnership, as was first reported by HealthInvestor.
29/09/2014
Apposite Capital portfolio company Ambit Biosciences has been acquired by pharmaceutical firm Daiichi Sankyo for $410 million (£252.5 million).
29/09/2014
UBS’s head of healthcare investment banking for the EMEA region, Will Thompson, has been hired by Barclays to join its own healthcare team.


The Barker Commission demands a closer look at how public sector funding works. But does it make a valid point?
Read more...
Is the Care Quality Commission over-policing the sector, or are the measures a proportionate reaction to a market that needs to get its act together?
Read more...
Monitor has unveiled shocking financial results for the NHS’ second quarter this year. Is the health service finally on the brink?
Private patient units at foundation trusts are not proving a threat to the private sector, yet
Changes are afoot at the Royal College of Nursing and it has potentially serious consequences for private care providers
Candesic’s Dr Joe Taylor argues mHealth is not a luxury, but a necessary element of 21st century medicine for care providers
European Care Group has rebranded as Embrace. Does this mean the future looks brighter for the firm though? Sunniva Davies-Rommetveit meets new CEO Trish Lee

Click here to search all feature articles